Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study) a randomised, placebo-controlled study /

Maher Toby M, Stowasser Susanne, Nishioka Yasuhiko, White Eric S, Cottin Vincent, Noth Imre, Selman Moisés, Rohr Klaus B, Michael Andreas, Ittrich Carina, Diefenbach Claudia, Jenkins R Gisli, Kollaborációs szervezet: INMARK trial investigators, Somfay Attila, et al
2019